Variant report
Variant | esv1800496 |
---|---|
Chromosome Location | chr6:120585486-120599836 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs540765381 | chr6:120594405-120594406 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs535554716 | chr6:120594422-120594423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs145062990 | chr6:120594529-120594530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs181008866 | chr6:120594549-120594550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs184528454 | chr6:120594554-120594555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs78323925 | chr6:120594557-120594558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs189052729 | chr6:120594570-120594571 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs575821403 | chr6:120594582-120594583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs138890575 | chr6:120594609-120594610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs550149523 | chr6:120594620-120594621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs570146478 | chr6:120594646-120594647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs539123690 | chr6:120594651-120594652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs76970605 | chr6:120594678-120594679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs115478569 | chr6:120594733-120594734 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs117913756 | chr6:120594826-120594827 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs79666221 | chr6:120594829-120594830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs555929869 | chr6:120594854-120594855 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs575845041 | chr6:120594859-120594860 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs544962275 | chr6:120594940-120594941 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs34850816 | chr6:120594960-120594961 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs543360570 | chr6:120594990-120594991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs111441767 | chr6:120594995-120594996 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs149081354 | chr6:120594999-120595000 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs372860564 | chr6:120595031-120595032 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs143152496 | chr6:120595059-120595060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs148271678 | chr6:120595116-120595117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs529401085 | chr6:120595144-120595145 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs546860305 | chr6:120595171-120595172 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs141349031 | chr6:120595190-120595191 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs561956812 | chr6:120595203-120595204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs530698292 | chr6:120595205-120595206 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs207467401 | chr6:120595259-120595260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs570433493 | chr6:120595287-120595288 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs7755668 | chr6:120595314-120595315 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs74393248 | chr6:120595339-120595340 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs541037496 | chr6:120595389-120595390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs181199950 | chr6:120595404-120595405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs559060624 | chr6:120595480-120595481 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs185295310 | chr6:120595485-120595486 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs73522833 | chr6:120595499-120595500 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs555672771 | chr6:120595502-120595503 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs114409784 | chr6:120595520-120595521 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs538519206 | chr6:120595521-120595522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs558463536 | chr6:120595530-120595531 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs578254439 | chr6:120595541-120595542 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112060051 | chr6:120595625-120595626 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs190669352 | chr6:120595678-120595679 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs181553468 | chr6:120595690-120595691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs532391371 | chr6:120595740-120595741 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs75348793 | chr6:120595741-120595742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Biliary cancer | 19435499 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Autism | 22495311 | CNVD |
Gastric cancer | 17908304 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 19010834 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 16608533 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Prostate cancer | 16705090 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Ependymoma | 16718352 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 19242612 | CNVD |
Glioma | 21046410 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Zellweger syndrome | 21572526 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Malignant melanoma | 18718029 | CNVD |
Lung adenocarcinoma | 21935476 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Chondromyxoid Fibroma | 20696777 | CNVD |
Cancer | 21183584 | CNVD |
Developmental delay | 19490664 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Ovarian cancer | 21720365 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21785460 | CNVD |
Prostate cancer | 16461572 | CNVD |
Neurocytoma | 17123091 | CNVD |
Cancer | 20164920 | CNVD |
Breast cancer | 21364760 | CNVD |
Chordoma | 21602918 | CNVD |
Kartagener syndrome | 16639409 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17133270 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Mental retardation | 17621639 | CNVD |
Hypoplastic | 20877625 | CNVD |
Hypotonia | 20877625 | CNVD |
Mental retardation | 20877625 | CNVD |
Microcephaly | 20877625 | CNVD |
brachycephaly | 20877625 | CNVD |
epicanthic folds | 20877625 | CNVD |
micrognathia | 20877625 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Breast cancer | 18698023 | CNVD |
Mental retardation | 18854857 | CNVD |
Leukemia | 18688285 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Intellectual disability | 22045946 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Breast cancer | 21611746 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:120594400-120596000 | Enhancers | Fetal Lung | lung |
2 | chr6:120595200-120596400 | Enhancers | Primary B cells from cord blood | blood |
3 | chr6:120595200-120596400 | Enhancers | Primary B cells from peripheral blood | blood |
4 | chr6:120596000-120599200 | Weak transcription | Fetal Lung | lung |
5 | chr6:120598000-120598400 | Enhancers | Fetal Brain Female | brain |
6 | chr6:120598200-120600400 | Enhancers | Fetal Brain Male | brain |
7 | chr6:120598400-120600000 | Weak transcription | Fetal Brain Female | brain |
8 | chr6:120599000-120599200 | Enhancers | Fetal Heart | heart |
9 | chr6:120599200-120600000 | Enhancers | Fetal Lung | lung |
10 | chr6:120599200-120600200 | Weak transcription | Fetal Heart | heart |
11 | chr6:120599600-120600000 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr6:120599800-120600200 | Enhancers | Fetal Muscle Leg | muscle |
13 | chr6:120599800-120600400 | Enhancers | HUES48 Cell Line | embryonic stem cell |